Type
|
Public |
---|---|
Traded as | NYSE: CC S&P 400 Component |
Industry | Performance chemicals, titanium dioxide, Viton |
Founded | 2015 (2015) |
Headquarters | Wilmington, Delaware, United States |
Area served
|
Global |
Key people
|
Mark P. Vergnano (CEO), Richard H. Brown (Chairman) |
Products |
Products list
|
Revenue | US$5.71 billion (2015) |
Operating income
|
US$-132 million (2015) |
Net income
|
US$-90 million (2015) |
Total assets | US$6.29 billion (2015) |
Total equity | US$126 million (2015) |
Subsidiaries |
Subsidiaries list
|
Website | Chemours.com |
The Chemours Company, commonly referred to as Chemours, is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States.
In October 2013, DuPont announced that it was planning to spin off its "performance chemicals" business into a new publicly traded company in mid-2015. DuPont filed its initial Form 10 with the SEC in December 2014 and announced that the new company would be called "The Chemours Company". The spin-off to DuPont shareholders was completed on July 1, 2015 and Chemours' stock began trading on the New York Stock Exchange on the same date. Its 180,920,858 shares of common stock were distributed to DuPont shareholders at a par value of one cent each. Chemours has assumed various liabilities arising from lawsuits against DuPont.
Chemours manufactures and sells performance chemicals falling within three segments: Titanium Technologies (titanium dioxide); Fluoroproducts (refrigerants and industrial fluoropolymer resins and derivatives including Freon, Teflon and Viton); and Chemical Solutions (cyanide, sulfuric acid, aniline, methylamines, and reactive metals).
Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-11-02 | Future report Set alerts | |
Q2 2022 | 2022-07-28 | 1.89 | 1.89 |
Q1 2022 | 2022-05-02 | 1.46 | 1.46 |
Q4 2021 | 2022-02-10 | 0.81 | 0.81 |
Q3 2021 | 2021-11-04 | 1.27 | 1.27 |
Q2 2021 | 2021-07-29 | 1.20 | 1.20 |
Q1 2021 | 2021-05-03 | 0.71 | 0.71 |
Q4 2020 | 2021-02-11 | 0.61 | 0.61 |
Q3 2020 | 2020-11-03 | 0.00 | 0.00 |
Q2 2020 | 2020-07-30 | 0.18 | 0.15 |
2016-06-15 | Reiterated Rating | Jefferies Group | Hold | |
2016-05-13 | Reiterated Rating | Argus | Hold | |
2016-05-09 | Boost Price Target | Barclays | Overweight | $14.00 to $15.00 |
2016-05-09 | Boost Price Target | Barclays PLC | Overweight | $14.00 to $15.00 |
2016-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Hold | |
2016-04-18 | Boost Price Target | Citigroup Inc. | Neutral | $5.00 to $8.00 |
2016-04-13 | Reiterated Rating | Jefferies Group | Hold | |
2016-03-14 | Upgrade | Goldman Sachs | Neutral to Buy | $6.00 to $10.00 |
2016-03-14 | Upgrade | Goldman Sachs Group Inc. | Neutral to Buy | $6.00 to $10.00 |
2016-02-16 | Downgrade | Jefferies | Buy to Hold | $4.50 |
2016-02-16 | Downgrade | Jefferies Group | Buy to Hold | $4.50 |
2016-01-05 | Lower Price Target | Citigroup Inc. | $7.00 to $6.00 | |
2015-12-18 | Reiterated Rating | Barclays | Overweight | $19.00 to $14.00 |
2015-11-06 | Lower Price Target | Barclays | Overweight | $24.00 to $19.00 |
2015-09-28 | Lower Price Target | Jefferies Group | Buy | $24.00 to $17.00 |
2015-09-18 | Initiated Coverage | Argus | Hold | |
2015-08-14 | Initiated Coverage | Citigroup Inc. | Neutral | $11.50 |
2015-08-07 | Upgrade | JPMorgan Chase & Co. | Underweight to Neutral | $16.00 to $11.00 |
2015-07-27 | Initiated Coverage | Susquehanna | Neutral | $13.00 |
2015-07-15 | Initiated Coverage | Goldman Sachs | Neutral | $15.00 |
2015-07-06 | Initiated Coverage | Barclays | Overweight | $24.00 |
2015-06-24 | Initiated Coverage | JPMorgan Chase & Co. | Underweight | $16.00 |
2015-06-22 | Initiated Coverage | Jefferies Group | Buy | $24.00 |
2016-06-15 | Reiterated Rating | Jefferies Group | Hold | |
2016-05-13 | Reiterated Rating | Argus | Hold | |
2016-05-09 | Boost Price Target | Barclays | Overweight | $14.00 to $15.00 |
2016-05-09 | Boost Price Target | Barclays PLC | Overweight | $14.00 to $15.00 |
2016-05-04 | Reiterated Rating | JPMorgan Chase & Co. | Hold |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CC 340 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 17.99M |
Vanguard Group, Inc | 17.74M |
BlackRock Fund Advisors | 14.61M |
FMR LLC | 9.82M |
BlackRock Institutional Trust Company, N.A. | 4.73M |
STATE STREET CORP | 4.53M |
LSV ASSET MANAGEMENT | 3.11M |
BANK OF AMERICA CORP /DE/ | 2.30M |
DIMENSIONAL FUND ADVISORS LP | 2.23M |
GEODE CAPITAL MANAGEMENT, LLC | 2.06M |
JPMORGAN CHASE & CO | 1.71M |
NORTHERN TRUST CORP | 1.57M |
FIRST TRUST ADVISORS LP | 1.56M |
AMERIPRISE FINANCIAL INC | 1.52M |
MORGAN STANLEY | 1.36M |